Skip to main content
. 2021 Dec 16;10(24):e024033. doi: 10.1161/JAHA.121.024033

Figure 1. Preclinical tools in the assessment of cardiotoxicity mediated by anticancer drug candidates.

Figure 1

CM indicates cardiomyocytes; hERG, human ether‐a‐go‐go–related Gene; hiPSC, human induced pluripotent stem cells; and hiPSC‐CM, human induced pluripotent stem cell–derived cardiomyocytes.